sur Aytu BioPharma, Inc. (NASDAQ:AYTU)
Aytu BioPharma to Announce Q2 2025 Financial Results
Aytu BioPharma, Inc., a pharmaceutical company specializing in novel therapeutics, is set to disclose its operational and financial results for the second quarter of fiscal 2025. The announcement is scheduled for release after the market closes on February 12, 2025.
Following the release, the company will hold a conference call and webcast at 4:30 p.m. Eastern time. This event will provide an opportunity for an in-depth review of the results, accompanied by a question and answer session.
Those interested in joining the call can dial specific numbers for U.S. and international access, using the participant code 583044. The webcast will be streamed live and archived on the company's website. A replay will be available until February 26, 2025, requiring access code 51953.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Aytu BioPharma, Inc.